Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase II contract was awarded to Promiliad Biopharma Incorporated in April, 2019 for $746,516.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42AI118104-02 | Phase II | 746,516 | April 4, 2019 | |||||||
A STTR Phase I contract was awarded to Promiliad Biopharma Incorporated in September, 2018 for $297,825.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DC017641-01 | Phase I | 297,825 | September 1, 2018 | |||||||
A STTR Phase II contract was awarded to Promiliad Biopharma Incorporated in September, 2020 for $751,069.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42DC017641-02A1 | Phase II | 751,069 | September 1, 2020 | |||||||
A STTR Phase I contract was awarded to Promiliad Biopharma Incorporated in July, 2016 for $295,729.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI118104-01A1 | Phase I | 295,729 | July 15, 2016 | |||||||
A STTR Phase I contract was awarded to Promiliad Biopharma Incorporated for $137,162.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI060249-01A2 | Phase I | 137,162 | ||||||||
A SBIR Phase I contract was awarded to Promiliad Biopharma Incorporated for $137,162.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41AI060249-01A2 | Phase I | 137,162 | ||||||||
A STTR Phase II contract was awarded to Promiliad Biopharma Incorporated for $1,517,860.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AI065143-02A1 | Phase II | 1,517,860 | ||||||||
A STTR Phase II contract was awarded to Promiliad Biopharma Incorporated for $998,280.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42GM072158-02 | Phase II | 998,280 | ||||||||
A SBIR Phase I contract was awarded to Promiliad Biopharma Incorporated for $225,624.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI078646-01 | Phase I | 225,624 | ||||||||
A STTR Phase I contract was awarded to Promiliad Biopharma Incorporated for $279,271.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI065143-01A2 | Phase I | 279,271 | ||||||||
A SBIR Phase I contract was awarded to Promiliad Biopharma Incorporated for $171,569.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI077245-01A1 | Phase I | 171,569 | ||||||||
A SBIR Phase I contract was awarded to Promiliad Biopharma Incorporated for $279,271.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41AI065143-01A2 | Phase I | 279,271 | ||||||||
A STTR Phase I contract was awarded to Promiliad Biopharma Incorporated for $190,807.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DA026245-01 | Phase I | 190,807 | ||||||||
A SBIR Phase I contract was awarded to Promiliad Biopharma Incorporated for $100,024.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41GM072158-01 | Phase I | 100,024 | ||||||||
A SBIR Phase II contract was awarded to Promiliad Biopharma Incorporated for $998,280.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R42GM072158-02 | Phase II | 998,280 | ||||||||
A STTR Phase I contract was awarded to Promiliad Biopharma Incorporated for $100,024.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41GM072158-01 | Phase I | 100,024 | ||||||||
A SBIR Phase I contract was awarded to Promiliad Biopharma Incorporated for $287,766.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI106166-01A1 | Phase I | 287,766 |